CECCOLINI, MICHELA
CECCOLINI, MICHELA
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
2007 Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M.
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation.
2006 Tosi P; Zamagni E; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Baccarani M; Cavo M.
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
2008 Tosi P; Terragna C; Testoni N; Zamagni E; Renzulli M; Tacchetti P; Montanari E; Perrone G; Ceccolini M; Brioli A; Pallotti MC; Tura S; Baccarani M; Cavo M.
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
2006 Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M.
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone.
2006 Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M.
Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients
2013 Gerardo Musuraca, Serena De Matteis, Roberta Napolitano, Francesco Fabbri, Delia Cangini, Michela Ceccolini, Maria Benedetta Giannini, Alessandro Lucchesi, Sonia Ronconi, Cristina Papayannidis, Viviana Guadagnuolo, Giovanni Martinelli, Paolo Savini, Monica Tani, Patrizia Tosi, Dino Amadori, Pier Paolo Fattori, Wainer Zoli, Silvia Carloni
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
2006 Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Grafone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L.
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep)
2007 Terragna, C.; Renzulli, M.; Remondini, D.; Tagliafico, E.; Roncaglia, E.; Tosi, P.; Zamagni, E.; Tacchetti, P.; Perrone, G.; Ceccolini, M.; Brioli, Am.; Martinelli, G.; Baccarani, M.; Cavo, M.
Proteasome inhibitors: Bortezomib in multiple myeloma
2008 Cavo M.; Pallotti M.C.; Pantani L.; Petrucci A.; Brioli A.; Terragna C.; Testoni N.; Marzocchi G.; Durante S.; Ceccolini M.; Perrone G.; Tacchetti P.; Zamagni E.; Tosi P.; Baccarani M.
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
2009 Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M.
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
2005 CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERRAGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY.
Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.
2010 Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M.
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation
2009 Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.; Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. | Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini... D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation. | Tosi P; Zamagni E; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Baccarani M; Cavo M. | 2006-01-01 | ANNALS OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation. | Tosi P; Terragna C; Testoni N; Zamagni E; Renzulli M; Tacchetti P; Montanari E; Perrone G; Ceccol...ini M; Brioli A; Pallotti MC; Tura S; Baccarani M; Cavo M. | 2008-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. | Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; ...Tura S; Baccarani M; Cavo M. | 2006-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treatedwith zoledronic acid and thalidomide-dexamethasone. | Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'ArcoA; Ronconi S; Cellini... C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S;Baccarani M; Cavo M. | 2006-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients | Gerardo Musuraca, Serena De Matteis, Roberta Napolitano, Francesco Fabbri, Delia Cangini, Michela... Ceccolini, Maria Benedetta Giannini, Alessandro Lucchesi, Sonia Ronconi, Cristina Papayannidis, Viviana Guadagnuolo, Giovanni Martinelli, Paolo Savini, Monica Tani, Patrizia Tosi, Dino Amadori, Pier Paolo Fattori, Wainer Zoli, Silvia Carloni | 2013-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission. | Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Gr...afone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L. | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep) | Terragna, C.; Renzulli, M.; Remondini, D.; Tagliafico, E.; Roncaglia, E.; Tosi, P.; Zamagni, E.; ...Tacchetti, P.; Perrone, G.; Ceccolini, M.; Brioli, Am.; Martinelli, G.; Baccarani, M.; Cavo, M. | 2007-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Proteasome inhibitors: Bortezomib in multiple myeloma | Cavo M.; Pallotti M.C.; Pantani L.; Petrucci A.; Brioli A.; Terragna C.; Testoni N.; Marzocchi G....; Durante S.; Ceccolini M.; Perrone G.; Tacchetti P.; Zamagni E.; Tosi P.; Baccarani M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma. | Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda... A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M. | 2009-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. | CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERR...AGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency. | Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucc...i A; Baccarani M; Cavo M. | 2010-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation | Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.;... Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M. | 2009-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |